Study Name: Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
16 locations found
- GSK Investigational Site
Location: Cary, North Carolina 27518
- GSK Investigational Site
Location: Charlotte, North Carolina 28204
- GSK Investigational Site
Location: Greenville, South Carolina 29601
- GSK Investigational Site
Location: Orange Park, Florida 32073
- GSK Investigational Site
Location: Omaha, Nebraska 68198
- GSK Investigational Site
Location: Waco, Texas 76712
- GSK Investigational Site
Location: San Antonio, Texas 78229
- GSK Investigational Site
Location: Aurora, Colorado 80045
- GSK Investigational Site
Location: Chandler, Arizona 85224
- GSK Investigational Site
Location: Las Vegas, Nevada 89169
- GSK Investigational Site
Location: Burbank, California 91505
- GSK Investigational Site
Location: Oxnard, California 93030
- GSK Investigational Site
Location: Fresno, California 93720
- GSK Investigational Site
Location: Eugene, Oregon 97401
- GSK Investigational Site
Location: Vancouver, Washington 98684
- GSK Investigational Site
Location: Yakima, Washington 98902
|